×
A phase I study to assess the safety and tolerability of intravesical pembrolizumab in recurrent non-muscle invasive bladder cancer (NMIBC).
Woodcock VK., Purshouse K., Butcher C., Haddon C., Verrall G., Elhussein L., Salio M., Middleton MR., Cerundolo V., Crew J., Protheroe A.
DOI
10.1200/JCO.2019.37.7_suppl.406
Type
Conference paper
Publication Date
01/03/2019
Volume
37